Select your localized edition:

Close ×

More Ways to Connect

Discover one of our 28 local entrepreneurial communities »

Be the first to know as we launch in new countries and markets around the globe.

Interested in bringing MIT Technology Review to your local market?

MIT Technology ReviewMIT Technology Review - logo

 

Unsupported browser: Your browser does not meet modern web standards. See how it scores »

Rice is a plant that can be stored at room temperature for a long time, which is very important for the development of the vaccine. It’s estimated that worldwide, it costs $200 to $300 million each year to preserve vaccines at cold temperatures, explains Nochi. “Thus we termed our technology cold-chain-free vaccine. In addition, purification of the vaccine antigen from rice seed is not necessary, also causing a reduction in cost.”

Furthermore, abolishing the painful use of needles and syringes not only cuts costs, but also prevents pathogens from accidentally appearing in the vaccines and then spreading throughout the population, especially in underdeveloped countries where supplies are limited.

The researchers plan to prepare the rice-based vaccine in the form of a capsule or tablet for applications in humans, hence they don’t have plans to deliver the vaccine as a form of steamed rice. The rice-based vaccine is also suitable for prevention of other mucosal infectious diseases, such as influenza and HIV.

“Genetically altering plants for vaccinations is an important area of research, and the work being done by the Japanese researchers is very exciting,” says Carol Tacket, a professor of medicine at the Center for Vaccine Development at the University of Maryland School of Medicine. “Using plants to express vaccines is technically achievable, and the main barrier is identifying protective antigens–in other words, what proteins will protect when used as vaccines. It’s really identifying the right antigen to put in expressions.”

5 comments. Share your thoughts »

Credit: The Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo.

Tagged: Biomedicine, genome, genetics, disease, bacteria, vaccine

Reprints and Permissions | Send feedback to the editor

From the Archives

Close

Introducing MIT Technology Review Insider.

Already a Magazine subscriber?

You're automatically an Insider. It's easy to activate or upgrade your account.

Activate Your Account

Become an Insider

It's the new way to subscribe. Get even more of the tech news, research, and discoveries you crave.

Sign Up

Learn More

Find out why MIT Technology Review Insider is for you and explore your options.

Show Me
×

A Place of Inspiration

Understand the technologies that are changing business and driving the new global economy.

September 23-25, 2014
Register »